SCHEMBL2709225

SCHEMBL2709225

Cc1ccc(S(=O)(=O)OCCOCCOC(=O)C(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 4/20 0.50
CHRM3 P20309 4/20 0.50
CHRM2 P08172 3/20 0.50
CHRM4 P08173 3/20 0.50
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
ALDH1A1 P00352 3/20 0.44
CYP3A4 P08684 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PKM P14618 1/20 0.41
KDM4E B2RXH2 1/20 0.40
STAT3 P40763 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31651021 0.82 NPC1 (0.49) LMNACYP1A2ALDH1A1CYP3A4SMN1; SMN2
SCHEMBL31651007 0.82 NPC1 (0.49) LMNACYP1A2ALDH1A1CYP3A4SMN1; SMN2
SCHEMBL4285798 0.82 NPC1 (0.49) LMNACYP1A2ALDH1A1CYP3A4SMN1; SMN2
SCHEMBL20088146 0.80 ALDH1A1 (0.43) LMNAALDH1A1SMN1; SMN2PKMSTAT3
SCHEMBL2708882 0.80 ALDH1A1 (0.43) LMNAALDH1A1SMN1; SMN2PKMSTAT3
SCHEMBL881292 0.79 ALDH1A1 (0.53) LMNACYP1A2CYP2D6ALDH1A1CYP3A4
SCHEMBL18644929 0.79 ALDH1A1 (0.53) LMNACYP1A2CYP2D6ALDH1A1CYP3A4
SCHEMBL18613994 0.79 ALDH1A1 (0.53) LMNACYP1A2CYP2D6ALDH1A1CYP3A4
SCHEMBL1145153 0.79 ALDH1A1 (0.53) LMNACYP1A2CYP2D6ALDH1A1CYP3A4
SCHEMBL12865316 0.79 ALDH1A1 (0.53) LMNACYP1A2CYP2D6ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1718599-B1 SYNTHESIS OF STERICALLY HINDERED SECONDARY AMINOETHER ALCOHOLS EXXONMOBIL RES & ENG CO (US) 2012-05-02 EP disclosed
US-7524990-B2 Synthesis of sterically hindered secondary aminoether alcohols EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2009-04-28 US disclosed
EP-1718599-A4 SYNTHESIS OF STERICALLY HINDERED SECONDARY AMINOETHER ALCOHOLS EXXONMOBIL RES & ENG CO (US) 2008-06-25 EP disclosed
US-20070293705-A1 Synthesis of Sterically Hindered Secondary Aminoether Alcohols EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2007-12-20 US disclosed
CN-1922131-A Synthesis of sterically hindered secondary aminoether alcohols EXXONMOBIL RES & ENG CO (US) 2007-02-28 CN disclosed
EP-1718599-A1 SYNTHESIS OF STERICALLY HINDERED SECONDARY AMINOETHER ALCOHOLS ExxonMobil Research and Engineering Company (US) 2006-11-08 EP disclosed
WO-2005082835-A1 SYNTHESIS OF STERICALLY HINDERED SECONDARY AMINOETHER ALCOHOLS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2005-09-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293705-A1 Synthesis of Sterically Hindered Secondary Aminoether Alcohols ADH1A, AADAT, ALDH7A1 CHRM1 3294/4885CHRM3 2615/4885CHRM2 3661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.